RAF1 mutation leading to hypertrophic cardiomyopathy in a Chinese family with a history of sudden cardiac death: A diagnostic insight into Noonan syndrome

被引:1
|
作者
Zheng, Jingjing [1 ,2 ]
Peng, Longyun [3 ]
Cheng, Ruofei [1 ,2 ]
Li, Zhiyan [1 ,2 ]
Xie, Jianjie [1 ,2 ]
Huang, Erwen [1 ,2 ]
Cheng, Jianding [1 ,2 ]
Zhao, Qianhao [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Fac Forens Med, Zhongshan Sch Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Translat Forens Med Engn Technol Re, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2024年 / 12卷 / 01期
基金
中国国家自然科学基金;
关键词
hypertrophic cardiomyopathy; Noonan syndrome; RAF1; gene; RAS-HCM; whole-exome sequencing; OF-FUNCTION MUTATIONS; RARE VARIANTS; PHENOTYPE; SPECTRUM; OUTCOMES;
D O I
10.1002/mgg3.2290
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Hypertrophic cardiomyopathy (HCM) is predominantly caused by mutations in sarcomeric genes. However, a subset of cases is attributed to genetic disorders unrelated to sarcomeric genes, such as Noonan syndrome (NS) and other RASopathies. In this study, we present a family with a history of sudden cardiac death (SCD) and focus on two adults with syndromic left ventricular hypertrophy (LVH).Methods; Clinical evaluations, including echocardiography, were conducted to assess cardiac manifestations. Whole-exome sequencing was performed to identify potential genetic variants underlying syndromic LVH in the study participants.Results: Whole-exome sequencing revealed a missense variant in the RAF1 gene, c.782C>T (p.Pro261Leu). This variant confirmed the diagnosis of NS in the affected individuals.Conclusion: The findings of this study underscore the importance of family history investigation and genetic testing in diagnosing syndromic LVH. By identifying the underlying genetic cause, clinicians can better understand the etiology of RAS-HCM and its association with SCD in young adults.
引用
收藏
页数:9
相关论文
共 46 条
  • [21] Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
    Dong, Yan
    Yang, Wen
    Chen, Chongchong
    Ji, Jiamei
    Zheng, Wei
    Zhang, Fengxiang
    Yang, Bing
    Li, Xiaorong
    Zhou, Xiujuan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [22] PHENOTYPIC CONSEQUENCES AND THE MALIGNANCY RISK IN FAMILIAL NOONAN SYNDROME DUE TO A RARE P.S427G RAF1 MUTATION
    Pelc, M.
    Ciara, E.
    Jezela-Stanek, A.
    Krajewska-Walasek, M.
    GENETIC COUNSELING, 2016, 27 (03): : 325 - 333
  • [23] Expanding the cardiac spectrum of Noonan syndrome with RIT1 variant: Left main coronary artery atresia causing sudden death
    Ramond, Francis
    Duband, Sebastien
    Croisille, Pierre
    Cave, Helene
    Teyssier, Georges
    Adouard, Veronique
    Touraine, Renaud
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2017, 60 (06) : 299 - 302
  • [24] Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations
    Guo, Xiying
    Fan, Chaomei
    Wang, Yanping
    Wang, Miao
    Cai, Chi
    Yang, Yinjian
    Zhao, Shihua
    Duan, Fujian
    Li, Yishi
    MEDICINE, 2017, 96 (11)
  • [25] Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy: A case report with RAF1 770C>T mutant
    Wang, Xiaoqin
    Zhou, Kaiyu
    Hua, Yimin
    Li, Yifei
    MEDICINE, 2016, 95 (37)
  • [26] Electrocardiographic Screening for Hypertrophic Cardiomyopathy and Long QT Syndrome: The Drivers of Cost-Effectiveness for the Prevention of Sudden Cardiac Death
    Anderson, Brett R.
    McElligott, Sean
    Polsky, Daniel
    Vetter, Victoria L.
    PEDIATRIC CARDIOLOGY, 2014, 35 (02) : 323 - 331
  • [27] Electrocardiographic Screening for Hypertrophic Cardiomyopathy and Long QT Syndrome: The Drivers of Cost-Effectiveness for the Prevention of Sudden Cardiac Death
    Brett R. Anderson
    Sean McElligott
    Daniel Polsky
    Victoria L. Vetter
    Pediatric Cardiology, 2014, 35 : 323 - 331
  • [28] The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening
    Christiaans, Imke
    Birnie, Erwin
    van Langen, Irene M.
    van Spaendonck-Zwarts, Karin Y.
    van Tintelen, J. Peter
    van den Berg, Maarten P.
    Atsma, Douwe E.
    Helderman-van den Enden, Apollonia T. J. M.
    Pinto, Yigal M.
    Hermans-van Ast, J. F.
    Bonsel, Gouke J.
    Wilde, Arthur A. M.
    EUROPEAN HEART JOURNAL, 2010, 31 (07) : 842 - 848
  • [29] The novel RAF1 mutation p.(Gly361Ala) located outside the kinase domain of the CR3 region in two patients with Noonan syndrome, including one with a rare brain tumor
    Harms, Frederike L.
    Alawi, Malik
    Amor, David J.
    Tan, Tiong Y.
    Cuturilo, Goran
    Lissewski, Christina
    Brinkmann, Julia
    Schanze, Denny
    Kutsche, Kerstin
    Zenker, Martin
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2018, 176 (02) : 470 - 476
  • [30] Analysis of a Family with Brugada Syndrome and Sudden Cardiac Death Caused by a Novel Mutation of SCN5A
    Zhu, Yao-Bin
    Zhang, Jian-Hui
    Ji, Yuan-Yuan
    Hu, Ya-Nan
    Wang, Han-Lu
    Ruan, Dan-Dan
    Meng, Xiao-Rong
    Lin, Xin-Fu
    Luo, Jie-Wei
    Chen, Wei
    CARDIOLOGY RESEARCH AND PRACTICE, 2022, 2022